Inventor · disambiguated record

Zhiyuan Cao

Also filed as: CAO ZHIYUAN

29 granted patents·26 pending applications·62 citations·filing 2013–2025

94Inventor score

Technology areasA61K C07K C12N H04L A61P

Files withINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD39 INNOVATIVE CELLULAR THERAPEUTICS CO LTD10 ADVANCED NEW TECHNOLOGIES CO LTD1 ALIBABA GROUP HOLDING LTD1 AMAZON TECH INC1

Top patents by PatentIndex Score

55 records

0196US11104732B2Reducing immune inhibition induced by SIGLEC-15INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Aug 31, 2021·6 cites·22 claims
0295US10869888B2Modified cell expansion and uses thereofINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Granted Dec 22, 2020·10 cites·28 claims
0395US10561686B2Modified cell expansion and uses thereofINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted Feb 18, 2020·17 cites·9 claims
0495US9932405B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2017·Granted Apr 3, 2018·13 cites·8 claims
0594US10493139B2Humanized anti-CD19 antibody and use thereof with chimeric antigen receptorINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted Dec 3, 2019·9 cites·5 claims
0688US10793638B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted Oct 6, 2020·2 cites·15 claims
0787US10918667B2Modified cell expressing therapeutic agent and uses thereofINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Granted Feb 16, 2021·2 cites·14 claims
0882US11823118B1Models for early detection of delivery defects—unassigned delivery blocksAMAZON TECH INC·Filed 2021·Granted Nov 21, 2023·2 cites·20 claims
0982US2024218075A1Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
1081US2025188146A1Modified Cell Expansion and Uses ThereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
1179US12297267B2Humanized anti-CD19 antibody and use thereof with chimeric antigen receptorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Granted May 13, 2025·0 cites·16 claims
1278US11566223B2Chimeric antigen receptor cell preparation and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2018·Granted Jan 31, 2023·1 cites·21 claims
1376US11364289B2Humanized anti-CD19 antibody and use thereof with chimeric antigen receptorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2019·Granted Jun 21, 2022·0 cites·12 claims
1476US2025025506A1Engineered safety in cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
1572US12150960B2Modified cell expansion and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Nov 26, 2024·0 cites·7 claims
1672US11970548B2Nanobody target GCC and uses in chimeric antigen receptor cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Granted Apr 30, 2024·0 cites·9 claims
1772US2025171560A1Chimeric antigen receptor cells for treating solid tumorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
1871US11932700B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Mar 19, 2024·0 cites·9 claims
1971US11834502B2Reducing immune inhibition induced by SIGLEC-15INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Dec 5, 2023·0 cites·19 claims
2070US12240915B2Chimeric antigen receptor cells for treating solid tumorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2019·Granted Mar 4, 2025·0 cites·19 claims
2169US11161913B2Chimeric antigen receptor cells for treating solid tumorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Nov 2, 2021·0 cites·13 claims
2268US12076343B2Engineered safety in cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Sep 3, 2024·0 cites·20 claims
2368US11981920B2Modified cell with enhanced migration capabilityINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Granted May 14, 2024·0 cites·15 claims
2468US11633427B2Vaccine and uses thereof in cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Granted Apr 25, 2023·0 cites·8 claims
2568US2023226113A1Vaccine and Uses thereof in Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
2668US2022339193A1Modified Cell Expressing Therapeutic Agent and Uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
2766US11701385B2Modulation of cell function for immunotherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2019·Granted Jul 18, 2023·0 cites·14 claims
2865US2022000921A1Modified Cell Expressing Therapeutic Agent and Uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2019·Application pending·0 cites
2963US2024058337A1Managing Side Effects in T Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
3063US2025121005A1CAR and Polyspecific Binding Molecules Targeting Solid TumorsINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
3162US11235004B2Lymphocyte cell lines and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2018·Granted Feb 1, 2022·0 cites·26 claims
3262US2021161961A1Modified Cell Expressing Therapeutic Agent and Uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Application pending·0 cites
3361US2024075061A1Cell therapy activating lymphocyte in tmeINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
3460US2023032871A1Recombinant Viral Particle for Gene and/or Cellular TherapyINNOVATIVE CELLULARTHERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
3559US11833174B2Modified cell with enhanced functionality and cellular therapy thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Dec 5, 2023·0 cites·17 claims
3659US11739136B2Inducible dominant negative PD-1 and uses in adoptive cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Aug 29, 2023·0 cites·11 claims
3759US10654934B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted May 19, 2020·0 cites·33 claims
3857US11944645B2Modified cell and use thereof in gene and cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
3957US11866494B2CAR T therapy through uses of co-stimulationINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Granted Jan 9, 2024·0 cites·9 claims
4056US2024307442A1Modified Cell Targeting Tumor ECM and Cellular Therapy thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
4154US2021379149A1Increasing or Maintaining T-Cell Subpopulations in Adoptive T-Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
4253US2023201258A1Polyspecific Binding Molecules and their use in Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Application pending·0 cites
4352US2023322899A1Fusion protein enhancing cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Application pending·0 cites
4452US2021060069A1Coupled redirected cells and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Application pending·0 cites
4552US2024024476A1CAR Cells and Polyspecific Binding Molecules for Treating Solid TumorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
4652US2021100841A1Presenting cell and use thereof in cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Application pending·0 cites
4752US2021137983A1Nk cell expansion and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Application pending·0 cites
4851US10958749B2Method and device for pushing application messageADVANCED NEW TECHNOLOGIES CO LTD·Filed 2019·Granted Mar 23, 2021·0 cites·18 claims
4951US2023201440A1System and method for gene and/or cellular therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Application pending·0 cites
5050US2022096546A1Modified Cell Expansion and Uses ThereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Application pending·0 cites

Showing the top 50 of 55 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Zhiyuan Cao files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →